Hospital tenders for adult incontinence products rarely turn on one number. Evaluators usually run bids through several filters. Supplier qualification and compliance documents come first, then lab or specification evidence, then ward-level product assessment, and finally a price or total-cost comparison. A bid can fail at any filter, and a low price only counts if the bid survives the earlier ones. For manufacturers, distributors, and private-label suppliers, this changes how a response should be built. The question is no longer “is our brief absorbent enough?” It is whether you can prove, with comparable data, that the product performs on a ward, that bulk shipments will match the sample, and that supply can be sustained. This article explains how those filters typically work and what to prepare before you bid.
Most hospital and public-sector tenders combine pass/fail requirements with weighted scoring. Mandatory criteria remove non-compliant bids. Scored criteria then compare the remaining bids on quality, service, and cost.
Research shows this pattern. A review of healthcare tenders in the International Journal of Technology Assessment in Health Care examined medical technology tenders collected during 2015. It found few price-only tenders (11 of 226) and summed scores as the most common scoring method. A majority of the weighting, around 64%, went to quality criteria. “Total cost” appeared often in the documents but was used inconsistently. The sample covers medical technology in general, not incontinence products, and it is a decade old. Treat it as a pattern, not a benchmark for any single tender.
In the European Union, Directive 2014/24/EU lets contracting authorities identify the most economically advantageous tender using a cost-effectiveness approach such as life-cycle costing, not price alone. How far a hospital uses that flexibility depends on national law and the tender documents.
| Evaluation stage | What the evaluator asks | Typical evidence requested | Common reason a bid drops out |
|---|---|---|---|
| 1. Qualification and compliance | Is the supplier legally and operationally able to supply? | Quality-system certificates, conformity declarations where applicable, insurance, sustainability or social-value responses | Certificates held by a different legal entity, with no agreement linking them to the bidder |
| 2. Technical specification | Does each product meet the stated performance and construction requirements? | Named test methods, per-SKU and per-size lab reports, material and construction declarations | Reports without test conditions, or testing of only one size |
| 3. Ward or clinical assessment | Does it work for staff and patients in real care scenarios? | Ward-ready samples, trial participation, sizing support, staff feedback scoring | Samples that differ from the bulk product, or poor fit across body types |
| 4. Commercial and supply | What does it cost, and can supply be sustained? | Price schedule, pack configuration, lead time, continuity plan, change-control terms | Pack configurations that change after award, vague supply commitments |
The table is a synthesis of the sources cited in this article, not a universal tender template. Order matters. A supplier with an excellent ward result still loses if its paperwork fails at stage 1. A polished compliance file cannot rescue a product that leaks on a night shift.
Stage 1 is mostly documentary. NHS Supply Chain’s prior information notice for disposable and washable continence care shows what a large public buyer signals before an invitation to tender. It said applicants may need to provide:
It also said applicants must hold a Carbon Reduction Plan, and that social-value questions would carry a minimum 10% weighting.
One detail is easy to miss. Where quality certificates are not in the applicant’s own name, the applicant must supply agreements setting out the responsibilities of every party in the supply chain. Distributors and private-label brands that source from a factory face this directly.
This was a pre-tender notice, and final requirements sit in the invitation to tender. Requirements also differ between markets. Whether an adult incontinence product is regulated as a medical device depends on the jurisdiction and the product’s claims. Confirm the classification with a regulatory specialist rather than assuming it.
Some public purchasers write acquisition and rewet limits into specifications and ask for laboratory evidence instead of brochure claims.
California’s Medi-Cal program offers a clear public example. Its incontinence products review and contracting procedures (April 2022 revision) set target values for briefs and for protective underwear:
Acquisition and rewet must follow NWSP 070.9.R1. The procedures require test reports for medium and large sizes and a laboratory that is not affiliated with the manufacturer, distributor, or supplier. A product may still be considered if only one parameter misses its target by no more than 15%.
Keep the scope in view. Medi-Cal is a state Medicaid product review and contracting process, not a hospital tender, and these values reflect its own policy choices. They show how a public buyer structures a specification: a named method, a defined parameter, a target, and independent data. They are not thresholds to copy into a hospital document.
Total capacity measures how much fluid a product can hold. It does not measure how fast the product takes in a void, or whether the surface stays dry under body weight. A bid that leads with a large capacity figure and says little about acquisition and rewet invites the questions an experienced evaluator will ask.
| Test claim | What it tells the evaluator | What it does not tell them | What a bidder should supply |
|---|---|---|---|
| Total capacity (for example ISO 11948-1) | Maximum fluid the whole product holds in a lab setup | Intake speed, surface dryness, leakage in use | Method, edition, sample size, sizes tested |
| Rate of acquisition | Speed of fluid intake | Behavior once the core is partly loaded | Dose volume, number of doses, interval |
| Rewet | Surface wetness returned under load | Capacity or fit | Applied pressure, which dose preceded measurement |
| Retention capacity | Fluid held without leaking or rewetting | Performance across repeated voids | Method reference, since it may be buyer-specific |
| Multi-dose testing | Performance after repeated voids | Fit, comfort, staff usability | Full protocol, independent laboratory |
This is a qualitative comparison and contains no measured values. The gap between single-insult versus multi-insult testing matters most for heavy, overnight, and institutional tiers, where wear time spans several voids. Two reports can both say “rewet” and still be impossible to compare. Evaluators who understand this ask for dose count, volume, interval, and load.
Test methods have a scope too. EDANA’s guidance on its Absorption Before Leakage test method says the method was developed for moderate and severe incontinence products used by bedridden patients. It also says results for out-of-scope products are meaningless because of high variability. EDANA notes that buyers or payers sometimes request ABL results across a whole product range. A bidder who can explain why a method does or does not suit a given product looks more credible than one who produces a number for every line.
A tender approves a product at one point in time, but the hospital buys it for years. The sample sent for assessment is the best-case product. If the nonwoven, superabsorbent polymer, or elastic changes after award and the specification sets no limits, nothing has technically been breached.
That is why material tolerances in the specification, per-lot certificates of analysis, and change-control commitments belong in a bid. They show the supplier expects the approved product to be the delivered product. Tighter limits are not automatically better, though. They must match what the production process and the test method can reliably hold. Otherwise the limit becomes a source of disputes instead of protection.
Ward assessment is where specification-compliant products still lose. Documents do not show whether a brief can be applied quickly to a patient who cannot stand, or whether it stays in position after repositioning.
NHS Supply Chain’s notice said applicants may be required to submit ward-ready samples for each tendered product. It also said product testing may be used at any point during the tender process and during the life of the framework agreement. Bidders should expect samples to work as a continuing quality check, not just an entry hurdle.
Panels often separate products by care scenario instead of scoring one brief for everyone. The same notice splits the market into lots including pull-ups, all-in-ones, belted products, pads for fixation pants, and accessory products such as procedure pads and sheets. For bedbound or post-operative patients, refastenable tab-style briefs that open flat are often argued to suit the workflow better. The manufacturer’s analysis of why hospitals often prefer tab-style adult diapers sets out that case. Mobile, self-toileting patients may do better with pull-ups. Underpads are usually judged as a separate item. The procurement checklist for hospital and nursing-home underpads covers intake speed, rewet, backsheet, and pack discipline for that category.
Ward assessments commonly examine:
Sample discipline decides how this goes. Send production-run product in the sizes you are bidding, in the pack format you intend to supply.
Not necessarily. In tenders that score total cost, a brief that is cheaper per unit can be the more expensive product in use.
A leak is a bundle of costs: a brief change, a wipe-down, sometimes a gown and fitted-sheet change, plus nursing time. The analysis of the hidden cost of leakage in institutional care shows how those costs sit in different budgets. It also shows why a small price gap per brief can be outweighed by labor and linen. Frameworks that allow life-cycle costing, like the EU directive above, give evaluators a basis to count them.
This holds only when the tender is built to measure total cost and when the supplier can show lower leakage. In a price-only or heavily pass/fail tender, unit price decides among compliant bids. There, a supplier should meet the specification exactly, avoid overbuilding, and price from a known cost structure. Evidence of savings should come from the buyer’s own trial data or a transparent model, not generic claims.
Several failure modes recur. They follow from how evaluation is structured and from the documents reviewed for this article. They are not a measured survey of failed bids.
Building the evidence pack before a tender opens is cheaper than assembling it under deadline. A workable checklist:
Suppliers can also see how a manufacturer packages its own documentation. LOVINHUG’s third-party test reports and certification documents page describes per-SKU reports covering absorption, rewet, leakage, and breathability, plus quality-system and compliance files on request. Whatever a supplier offers, buyers should ask to see the actual documents. They should check the legal entity named on each and confirm that test conditions match the tender specification.
Hospital buyers can use the same list in reverse as a scoring frame. If a bid cannot answer most of it, the evaluator has learned about delivery risk before the first carton ships.
Most start with mandatory criteria: supplier qualification, quality-system certificates, applicable regulatory documents, and insurance. Bids that fail these are removed before technical or price scoring. Exact requirements vary by country and by tender document.
Common measures include rate of acquisition, rewet, retention or total capacity, and sometimes breathability, often by named methods such as NWSP 070.9.R1 or ISO 11948-1. Heavy-use products may also need multi-dose data. Requirements differ between buyers.
No. Many tenders use weighted scoring with quality criteria, and some frameworks allow life-cycle costing. Price-only or strictly pass/fail tenders also exist, so the answer depends on how the tender is written.
Often. Buyers may request ward-ready samples and may test products during and after the tender. Panels commonly assess fit, ease of application, stability after repositioning, and surface dryness, so samples should match the production product.
Frequently. Medi-Cal’s published procedure, for example, requires a laboratory unaffiliated with the supplier and results for medium and large sizes. Check each tender’s wording, because requirements for sizes, methods, and lab independence vary.
Rewet depends on dose volume, number of doses, interval, applied load, and measurement timing. Without matching conditions the numbers measure different things. Evaluators should request full protocols or retest all candidates under one method.
Professional Adult Incontinence Products Manufacturer | OEM / ODM Since 2010
Premium adult diapers, incontinence pads, underpads, and OEM/ODM solutions tailored to your market.
